Wendy S. Johnson

Insider Reports History

Location
Richmond, VA
Signature
/s/ Kamal Adawi, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Wendy S. Johnson:

Company Role Class Num Shares Value Price $ Report Date Ownership
EXAGEN INC. Director Stock Option(right to buy) 9,000 $32,220 $3.58 09 Jun 2023 Direct
Reneo Pharmaceuticals, Inc. Chief Development Officer Common Stock 0 $6.28 14 Jul 2021 Direct
Reneo Pharmaceuticals, Inc. Chief Development Officer Stock option (right to buy) 0 08 Jul 2021 Direct

Insider Reports Filed by Wendy S. Johnson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XGN EXAGEN INC. 09 Jun 2023 1 $0 4 Director 13 Jun 2023, 16:35
XGN EXAGEN INC. 16 Jun 2022 1 $0 4 Director 21 Jun 2022, 08:34
XGN EXAGEN INC. 03 Sep 2021 1 +$14,020 4 Director 07 Sep 2021, 08:25
RPHM Reneo Pharmaceuticals, Inc. 14 Jul 2021 1 -$949,756 4 Chief Development Officer 15 Jul 2021, 17:33
RPHM Reneo Pharmaceuticals, Inc. 08 Jul 2021 2 +$220,120 4 Chief Development Officer 09 Jul 2021, 18:52
XGN EXAGEN INC. 17 Jun 2021 1 $0 4 Director 21 Jun 2021, 08:38